Skip to main content

Rajendra Karki

Seoul National University · Biochemistry, Genetics and Molecular Biology

About the Lab

Professor Rajendra Karki's research lab focuses on the molecular mechanisms of regulated cell death, particularly PANoptosis, and its roles in inflammation, cancer immunosurveillance, and tissue homeostasis. The lab investigates key regulators such as ZBP1, ADAR1, IRF1, and NLR family proteins in controlling cell death pathways and their impact on tumorigenesis, especially in colorectal cancer. Using genetically engineered mouse models and systems-level analyses, the lab explores crosstalk between cell death pathways and innate immune responses in the tumor microenvironment. Additionally, the lab examines natural compounds, such as those from *Nelumbo nucifera*, for their potential immunomodulatory and anti-tumorigenic properties.

regulated cell deathPANoptosisinflammation and cancerinnate immunitytumor suppressor proteins

Research Overview

Papers
116
Total Citations
16,355
Papers (5y)
27
Primary Field
Biochemistry, Genetics and Molecular Biology

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
27total
2022
2023
2024
2025
2026
Citations per year (5y)
1,363total
20222023202420252026

Selected Papers

15
1
Article|1,709 citations·2020
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
Rajendra Karki, Bhesh Raj Sharma, Shraddha Tuladhar, Evan P. Williams, Lillian Zalduondo, Parimal Samir, Min Zheng, Balamurugan Sundaram, Balaji Banoth, R. K. Subbarao Malireddi, Patrick Schreiner, Geoffrey Neale
SJR Q1CellOA
Infectious DiseasesMedicine
2
Review|665 citations·2019
Diverging inflammasome signals in tumorigenesis and potential targeting
Rajendra Karki, Thirumala‐Devi Kanneganti
SJR Q1Nature reviews. CancerOA
Molecular BiologyBiochemistry, Genetics and Molecular Biology
3
Review|412 citations·2021
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Rajendra Karki, Thirumala‐Devi Kanneganti
SJR Q1Trends in ImmunologyOA
ImmunologyImmunology and Microbiology
4
Article|404 citations·2021
ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis
Rajendra Karki, Balamurugan Sundaram, Bhesh Raj Sharma, SangJoon Lee, R. K. Subbarao Malireddi, Lam Nhat Nguyen, Shelbi Christgen, Min Zheng, Yaqiu Wang, Parimal Samir, Geoffrey Neale, Peter Vogel
SJR Q1Cell ReportsOA

Cell death provides host defense and maintains homeostasis. Zα-containing molecules are essential for these processes. Z-DNA binding protein 1 (ZBP1) activates inflammatory cell death, PANoptosis, whereas adenosine deaminase acting on RNA 1 (ADAR1) serves as an RNA editor to maintain homeostasis. Here, we identify and characterize ADAR1's interaction with ZBP1, defining its role in cell death regulation and tumorigenesis. Combining interferons (IFNs) and nuclear export inhibitors (NEIs) activate

Molecular BiologyBiochemistry, Genetics and Molecular Biology
5
Review|386 citations·2017
Inflammasomes and Cancer
Rajendra Karki, Si Ming Man, Thirumala‐Devi Kanneganti
SJR Q1Cancer Immunology ResearchOA

Inflammation affects all stages of tumorigenesis. A key signaling pathway leading to acute and chronic inflammation is through activation of the caspase-1 inflammasome. Inflammasome complexes are assembled on activation of certain nucleotide-binding domain, leucine-rich repeat-containing proteins (NLR), AIM2-like receptors, or pyrin. Of these, NLRP1, NLRP3, NLRC4, NLRP6, and AIM2 influence the pathogenesis of cancer by modulating innate and adaptive immune responses, cell death, proliferation, a

Molecular BiologyBiochemistry, Genetics and Molecular Biology
6
Article|276 citations·2020
Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer
Rajendra Karki, Bhesh Raj Sharma, Ein Lee, Balaji Banoth, R. K. Subbarao Malireddi, Parimal Samir, Shraddha Tuladhar, Harisankeerth Mummareddy, Amanda R. Burton, Peter Vogel, Thirumala‐Devi Kanneganti
SJR Q1JCI InsightOA

Interferon regulatory factor 1 (IRF1) regulates diverse biological functions, including modulation of cellular responses involved in tumorigenesis. Genetic mutations and altered IRF1 function are associated with several cancers. Although the function of IRF1 in the immunobiology of cancer is emerging, IRF1-specific mechanisms regulating tumorigenesis and tissue homeostasis in vivo are not clear. Here, we found that mice lacking IRF1 were hypersusceptible to colorectal tumorigenesis. IRF1 functio

Molecular BiologyBiochemistry, Genetics and Molecular Biology
7
Article|275 citations·2015
Concerted Activation of the AIM2 and NLRP3 Inflammasomes Orchestrates Host Protection against Aspergillus Infection
Rajendra Karki, Si Ming Man, R. K. Subbarao Malireddi, Prajwal Gurung, Peter Vogel, Mohamed Lamkanfi, Thirumala‐Devi Kanneganti
SJR Q1Cell Host & MicrobeOA
Molecular BiologyBiochemistry, Genetics and Molecular Biology
8
Article|220 citations·2016
NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
Rajendra Karki, Si Ming Man, R. K. Subbarao Malireddi, Sannula Kesavardhana, Qifan Zhu, Amanda R. Burton, Bhesh Raj Sharma, Xiaopeng Qi, S. William Pelletier, Peter Vogel, Philip Rosenstiel, Thirumala‐Devi Kanneganti
SJR Q1NatureOA
ImmunologyImmunology and Microbiology
9
Review|196 citations·2016
A Comprehensive Review on Chemical Profiling of Nelumbo Nucifera: Potential for Drug Development
Bhesh Raj Sharma, Lekh Nath S. Gautam, Deepak Adhikari, Rajendra Karki
SJR Q1Phytotherapy Research

Nelumbo nucifera, also known as sacred lotus, has primarily been used as food throughout the Asian continent, and its medicinal values have been described in Ayurvedic and Traditional Chinese Medicine. The purpose of this study is to systematically characterize the chemical profiling and pharmacological activities of N. nucifera. Herein, we critically reviewed and analysed the phytochemical and pharmacological reports of N. nucifera. Our search for the keyword 'Nelumbo nucifera pharmacology' in

Analytical ChemistryChemistry
10
Article|175 citations·2018
IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation
Rajendra Karki, Ein Lee, David E. Place, Parimal Samir, Jayadev Mavuluri, Bhesh Raj Sharma, Arjun Balakrishnan, R. K. Subbarao Malireddi, Rechel Geiger, Qifan Zhu, Geoffrey Neale, Thirumala‐Devi Kanneganti
SJR Q1CellOA
Molecular BiologyBiochemistry, Genetics and Molecular Biology
11
Review|133 citations·2023
Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis
Ein Lee, Chang‐Hyun Song, Sung‐Jin Bae, Ki‐Tae Ha, Rajendra Karki
SJR Q1Experimental & Molecular MedicineOA

Pyroptosis, apoptosis, necroptosis, and ferroptosis, which are the most well-studied regulated cell death (RCD) pathways, contribute to the clearance of infected or potentially neoplastic cells, highlighting their importance in homeostasis, host defense against pathogens, cancer, and a wide range of other pathologies. Although these four RCD pathways employ distinct molecular and cellular processes, emerging genetic and biochemical studies have suggested remarkable flexibility and crosstalk amon

Molecular BiologyBiochemistry, Genetics and Molecular Biology
12
Article|128 citations·2017
NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer
Rajendra Karki, R. K. Subbarao Malireddi, Qifan Zhu, Thirumala‐Devi Kanneganti
SJR Q1Cell CycleOA

Nucleotide-binding domain, leucine-rich-repeat–containing proteins (NLRs) are intracellular innate immune sensors of pathogen-associated and damage-associated molecular patterns. NLRs regulate diverse biologic processes such as inflammatory responses, cell proliferation and death, and gut microbiota to attenuate tumorigenesis. In a recent publication in Nature, we identified NLRC3 as a negative regulator of PI3K–mTOR signaling and characterized its potential tumor suppressor function. Enterocyte

Molecular BiologyBiochemistry, Genetics and Molecular Biology
13
Review|120 citations·2022
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
Rajendra Karki, Thirumala‐Devi Kanneganti
SJR Q1Journal of Translational MedicineOA

The innate immune system serves as the first line of defense against invading pathogens; however, dysregulated innate immune responses can induce aberrant inflammation that is detrimental to the host. Therefore, careful innate immune regulation is critical during infections. The coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has resulted in global morbidity and mortality as well as socio-economic stresses. Innate immune

Infectious DiseasesMedicine
14
Review|114 citations·2023
PANoptosome signaling and therapeutic implications in infection: central role for ZBP1 to activate the inflammasome and PANoptosis
Rajendra Karki, Thirumala‐Devi Kanneganti
SJR Q1Current Opinion in ImmunologyOA

The innate immune response provides the first line of defense against infection and disease. Regulated cell death (RCD) is a key component of innate immune activation, and RCD must be tightly controlled to clear pathogens while preventing excess inflammation. Recent studies have highlighted a central role for the innate immune sensor Z-DNA-binding protein 1 (ZBP1) as an activator of a form of inflammatory RCD called PANoptosis, which is regulated by a multifaceted cell death complex called the P

Molecular BiologyBiochemistry, Genetics and Molecular Biology
15
Review|112 citations·2018
Phytochemical profile and pharmacological activity of Aegle marmelos Linn.
Bikash Manandhar, Keshav Raj Paudel, Biraj Sharma, Rajendra Karki
SJR Q1Journal of Integrative Medicine
Endocrinology, Diabetes and MetabolismMedicine

Research Areas

Molecular BiologyImmunologyPharmacologyAnalytical ChemistryRehabilitationInfectious Diseases

Dive deeper into Rajendra Karki's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.